Trillium Therapeutics Inc (TRIL.CA) Stock Analyst Ratings
Canada - Toronto Stock Exchange - TSX:TRIL -
23.33
+0.11 (+0.47%)
ChartMill assigns a Buy % Consensus number of 78% to TRIL.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.87. This target is -19.12% below the current price.
TRIL.CA was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about TRIL.CA.
In the previous month the buy percentage consensus was at a similar level.
TRIL.CA was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-10-03 | Bloom Burton | Initiate | Hold |
Trillium Therapeutics Inc / TRIL.CA FAQ
What is the average price target for Trillium Therapeutics Inc (TRIL.CA) stock?
10 analysts have analysed TRIL.CA and the average price target is 18.87 null. This implies a price decrease of -19.12% is expected in the next year compared to the current price of 23.33.
How do analysts rate Trillium Therapeutics Inc (TRIL.CA)?
The consensus rating for Trillium Therapeutics Inc (TRIL.CA) is 78 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for TRIL stock?
The number of analysts covering Trillium Therapeutics Inc (TRIL.CA) is 10.